Patents by Inventor Peter P. Soltesz
Peter P. Soltesz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220202467Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: March 16, 2022Publication date: June 30, 2022Applicant: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 11304742Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: GrantFiled: October 2, 2019Date of Patent: April 19, 2022Assignee: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Publication number: 20200038086Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: October 2, 2019Publication date: February 6, 2020Applicant: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 10470811Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: GrantFiled: October 24, 2016Date of Patent: November 12, 2019Assignee: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Publication number: 20170258509Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: October 24, 2016Publication date: September 14, 2017Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 9486266Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: GrantFiled: September 20, 2013Date of Patent: November 8, 2016Assignee: PulmonX CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 9131942Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.Type: GrantFiled: March 6, 2013Date of Patent: September 15, 2015Assignee: PULMONX CORPORATIONInventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
-
Publication number: 20140081308Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.Type: ApplicationFiled: March 6, 2013Publication date: March 20, 2014Applicant: Pulmonx CorporationInventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
-
Publication number: 20140018605Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: September 20, 2013Publication date: January 16, 2014Applicant: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 8568403Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: GrantFiled: October 26, 2009Date of Patent: October 29, 2013Assignee: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 8409168Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.Type: GrantFiled: March 24, 2010Date of Patent: April 2, 2013Assignee: Pulmonx CorporationInventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
-
Patent number: 8177769Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: June 22, 2010Date of Patent: May 15, 2012Assignee: Pulmonx CorporationInventors: Rodney C. Perkins, Peter P. Soltesz, Robert Kotmel, Anthony D. Wondka
-
Publication number: 20100280538Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: ApplicationFiled: June 22, 2010Publication date: November 4, 2010Applicant: Pulmonx CorporationInventors: Rodney C. Perkins, Peter P. Soltesz, Robert Kotmel, Anthony D. Wondka
-
Patent number: 7766895Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: April 12, 2005Date of Patent: August 3, 2010Assignee: Pulmonx CorporationInventors: Peter P. Soltesz, Anthony D. Wondka, Rodney A. Perkins, Robert Kotmel
-
Publication number: 20100175693Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.Type: ApplicationFiled: March 24, 2010Publication date: July 15, 2010Applicant: Pulmonx CorporationInventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
-
Publication number: 20100042089Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: October 26, 2009Publication date: February 18, 2010Applicant: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 7628789Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: GrantFiled: July 28, 2006Date of Patent: December 8, 2009Assignee: Pulmonx CorporationInventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 7186259Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: January 26, 2004Date of Patent: March 6, 2007Assignee: PULMONxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
-
Patent number: 7141046Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: December 13, 2001Date of Patent: November 28, 2006Assignee: PulmonxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
-
Patent number: 6997918Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.Type: GrantFiled: March 4, 2003Date of Patent: February 14, 2006Assignee: PulmonxInventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch